Skip to Content

COVID-19 Vaccine Scammers Proliferating on the 'Dark Web'

MONDAY, Feb. 8, 2021 -- Online COVID-19 vaccine scams are becoming more widespread, security experts warn.

In the last six weeks, there has been a sharp rise in the number of COVID-19 vaccine ads on the "dark web" -- which connects unidentified buyers with anonymous sellers -- and the asking prices have doubled or even quadrupled, Mark Ostrowski, head of engineering for the cybersecurity company Check Point, told CBS News.

Searches conducted by his team revealed a wide range of offers, including a deal of 14 doses for $300 -- or $200 below the original $500 price -- that came with a promise of a 100 percent refund if the doses did not arrive. Another seller offered a bulk discount of 10,000 bottles of vaccine for $30,000, and another was asking $1,500 for four doses of a "Chinese vaccine."

Ostrowski's team even sent a Bitcoin payment to one seller to see what would happen. "Our expectations were low, and, of course, they weren't met," Ostrowski said.

As far as he can tell, none of the sellers actually has COVID-19 vaccines, CBS News reported. In December, INTERPOL warned law enforcement in 194 countries about organized crime groups targeting COVID-19 vaccines, both physically and online.

CBS News Article

© 2021 HealthDay. All rights reserved.

Read this next

Frequency of Urgent Vitreoretinal Surgery Down During Pandemic

FRIDAY, March 5, 2021 -- The frequency of urgent or emergent vitreoretinal surgical procedures decreased during the COVID-19 pandemic, according to a study published online March...

Delayed Local Reactions to mRNA-1273 Vaccination Reported

FRIDAY, March 5, 2021 -- Twelve cases of delayed large local reactions to the mRNA-1273 vaccination against severe acute respiratory syndrome coronavirus 2 are described in a...

Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19

FRIDAY, March 5, 2021 -- A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.